Cardlytics, Inc. (CDLX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 16.41 |
| Open | 16.87 |
| Bid | 16.80 x 800 |
| Ask | 16.99 x 800 |
| Day's Range | 16.28 - 17.53 |
| 52 Week Range | 2.57 - 19.57 |
| Volume | |
| Avg. Volume | 741,339 |
| Market Cap | 622.449M |
| Beta (5Y Monthly) | 1.83 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -13.46 |
| Earnings Date | Oct 30, 2023 - Nov 03, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for CDLX
Related Research
- Cardlytics, Inc. Common StockDaily – Vickers Top Buyers & Sellers for 09/12/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat19 days agoArgus Research
Barrons.comCardlytics, Immunocore, and More Stocks See Action From Activist Investors
CAS Investment Partners reached a cooperation agreement with digital-ad platform Cardlytics. General Atlantic trimmed its stake in pharmaceutical firm Immunocore.
GlobeNewswireCardlytics Appoints Alex Mishurov to its Board of Directors
ATLANTA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, is excited to announce the appointment of Alex Mishurov as an independent member of its Board of Directors. Mishurov will serve on the Board’s Compensation Committee, Nominating and Corporate Governance Committee and Transaction Committee. In connection with Mishurov’s appointment, Cardlytics entered into a cooperation agreement with CAS Investment Partners, a 14.4% st
GuruFocus.comInsider Sell: Cardlytics Inc CEO Karim Temsamani Sells 166,973 Shares
On September 8, 2023, Karim Temsamani, the CEO of Cardlytics Inc (NASDAQ:CDLX), sold 166,973 shares of the company.
